Neutrophil Extracellular Traps Effectively Control Acute Chikungunya Virus Infection
- PMID: 32082301
- PMCID: PMC7005923
- DOI: 10.3389/fimmu.2019.03108
Neutrophil Extracellular Traps Effectively Control Acute Chikungunya Virus Infection
Abstract
The Chikungunya virus (CHIKV) is a re-emerging arbovirus, in which its infection causes a febrile illness also commonly associated with severe joint pain and myalgia. Although the immune response to CHIKV has been studied, a better understanding of the virus-host interaction mechanisms may lead to more effective therapeutic interventions. In this context, neutrophil extracellular traps (NETs) have been described as a key mediator involved in the control of many pathogens, including several bacteria and viruses, but no reports of this important protective mechanism were documented during CHIKV infection. Here we demonstrate that the experimental infection of mouse-isolated neutrophils with CHIKV resulted in NETosis (NETs release) through a mechanism dependent on TLR7 activation and reactive oxygen species generation. In vitro, mouse-isolated neutrophils stimulated with phorbol 12-myristate 13-acetate release NETs that once incubated with CHIKV, resulting in further virus capture and neutralization. In vivo, NETs inhibition by the treatment of the mice with DNase resulted in the enhanced susceptibility of IFNAR-/- mice to CHIKV experimental acute infection. Lastly, by accessing the levels of MPO-DNA complex on the acutely CHIKV-infected patients, we found a correlation between the levels of NETs and the viral load in the blood, suggesting that NETs are also released in natural human infection cases. Altogether our findings characterize NETosis as a contributing natural process to control CHIKV acute infection, presenting an antiviral effect that helps to control systemic virus levels.
Keywords: Chikungunya; NETs; innate response; neutrophils; viral infection.
Copyright © 2020 Hiroki, Toller-Kawahisa, Fumagalli, Colon, Figueiredo, Fonseca, Franca and Cunha.
Figures
Similar articles
-
Distinct Roles of Interferon Alpha and Beta in Controlling Chikungunya Virus Replication and Modulating Neutrophil-Mediated Inflammation.J Virol. 2019 Dec 12;94(1):e00841-19. doi: 10.1128/JVI.00841-19. Print 2019 Dec 12. J Virol. 2019. PMID: 31619554 Free PMC article.
-
Critical role for bone marrow stromal antigen 2 in acute Chikungunya virus infection.J Gen Virol. 2014 Nov;95(Pt 11):2450-2461. doi: 10.1099/vir.0.068643-0. Epub 2014 Jul 22. J Gen Virol. 2014. PMID: 25053563 Free PMC article.
-
Loss of TLR3 aggravates CHIKV replication and pathology due to an altered virus-specific neutralizing antibody response.EMBO Mol Med. 2015 Jan;7(1):24-41. doi: 10.15252/emmm.201404459. EMBO Mol Med. 2015. PMID: 25452586 Free PMC article.
-
Chikungunya Virus-Induced Arthritis: Role of Host and Viral Factors in the Pathogenesis.Viral Immunol. 2017 Dec;30(10):691-702. doi: 10.1089/vim.2017.0052. Epub 2017 Sep 14. Viral Immunol. 2017. PMID: 28910194 Review.
-
Cellular and molecular mechanisms of chikungunya pathogenesis.Antiviral Res. 2015 Aug;120:165-74. doi: 10.1016/j.antiviral.2015.06.009. Epub 2015 Jun 16. Antiviral Res. 2015. PMID: 26092642 Review.
Cited by
-
Potential Pathways and Pathophysiological Implications of Viral Infection-Driven Activation of Kallikrein-Kinin System (KKS).Viruses. 2024 Feb 3;16(2):245. doi: 10.3390/v16020245. Viruses. 2024. PMID: 38400022 Free PMC article. Review.
-
Integrated control strategies for dengue, Zika, and Chikungunya virus infections.Front Immunol. 2023 Dec 18;14:1281667. doi: 10.3389/fimmu.2023.1281667. eCollection 2023. Front Immunol. 2023. PMID: 38196945 Free PMC article. Review.
-
Essential role of the CCL2-CCR2 axis in Mayaro virus-induced disease.J Virol. 2024 Jan 23;98(1):e0110223. doi: 10.1128/jvi.01102-23. Epub 2024 Jan 3. J Virol. 2024. PMID: 38169294 Free PMC article.
-
Immune Thrombosis: Exploring the Significance of Immune Complexes and NETosis.Biology (Basel). 2023 Oct 12;12(10):1332. doi: 10.3390/biology12101332. Biology (Basel). 2023. PMID: 37887042 Free PMC article. Review.
-
Preclinical efficacy of TZG in myofascial pain syndrome by impairing PI3K-RAC2 signaling-mediated neutrophil extracellular traps.iScience. 2023 Sep 27;26(10):108074. doi: 10.1016/j.isci.2023.108074. eCollection 2023 Oct 20. iScience. 2023. PMID: 37860777 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
